OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
Go back to OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 314.10 +12.58 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $301.52 | 52 Week High | $139.79 | |||
| Open | $299.78 | 52 Week Low | $82.07 | |||
| Day High | $314.94 | P/E | 730.47 | |||
| Day Low | $299.70 | EPS | $0.43 | |||
| Volume | 241,743 | |||||
| (NASDAQ: OABI) | Delayed: 4.74 +0.13 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.61 | 52 Week High | $ | |||
| Open | $4.61 | 52 Week Low | $ | |||
| Day High | $4.81 | P/E | N/A | |||
| Day Low | $4.55 | EPS | $ | |||
| Volume | 674,966 | |||||
